Page last updated: 2024-11-08

camalexin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

camalexin : An indole phytoalexin that is indole substituted at position 3 by a 1,3-thiazol-2-yl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID636970
CHEMBL ID239716
CHEBI ID22990
SCHEMBL ID343413
MeSH IDM0268159

Synonyms (31)

Synonym
CHEBI:22990 ,
3-thiazol-2'-yl-indole
1h-indole, 3-(2-thiazolyl)-
3-(1,3-thiazol-2-yl)-1h-indole
camalexin
inchi=1/c11h8n2s/c1-2-4-10-8(3-1)9(7-13-10)11-12-5-6-14-11/h1-7,13
3-(thiazol-2-yl)indole
CHEMBL239716
2-(1h-indol-3-yl)-1,3-thiazole
3-THIAZOL-2-YL-1H-INDOLE
SCHEMBL343413
3-(2-thiazolyl)-1h-indole
135531-86-1
(2z)-2-indol-3-ylidene-3h-1,3-thiazole
7wb ,
AKOS030257626
camalexin, >=98% (hplc)
2-(3-indolyl)thiazole
3-(2-thiazolyl)indole
E75026
C21721
AS-16652
Q19903715
BCP33171
3-(thiazol-2-yl)-1h-indole
CS-0068593
HY-119502
nsc-804228
nsc804228
DTXSID901032122
QY3Z69LA99

Research Excerpts

Overview

Camalexin is an integral part of Arabidopsis innate immunity, but the contribution of its biosynthesis in ISR is poorly investigated. It accumulates in various cruciferous plants upon exposure to environmental stress and plant pathogens.

ExcerptReferenceRelevance
"Camalexin is an integral part of Arabidopsis innate immunity, but the contribution of its biosynthesis in ISR is poorly investigated."( Priming of camalexin accumulation in induced systemic resistance by beneficial bacteria against Botrytis cinerea and Pseudomonas syringae pv. tomato DC3000.
Aziz, A; Baillieul, F; Clément, C; Nguyen, NH; Rabenoelina, F; Trotel-Aziz, P; Villaume, S, 2022
)
1.83
"Camalexin is a phytoalexin that accumulates in various cruciferous plants upon exposure to environmental stress and plant pathogens. "( Camalexin Induces Apoptosis via the ROS-ER Stress-Mitochondrial Apoptosis Pathway in AML Cells.
Cai, Z; Han, X; He, D; He, J; Wang, G; Wu, W; Yang, Y; Yao, S; Yu, R; Zhao, Y; Zheng, G, 2018
)
3.37
"Camalexin is a tryptophan-derived phytoalexin that is induced in the model plant Arabidopsis thaliana upon pathogen attack. "( De novo genetic engineering of the camalexin biosynthetic pathway.
Geu-Flores, F; Halkier, BA; Møldrup, ME; Olsen, CE; Salomonsen, B, 2013
)
2.11
"Camalexin is a phytoalexin of Arabidopsis thaliana and an important component of inducible defenses. "( Quantification of camalexin, a phytoalexin from Arabidopsis thaliana: a comparison of five analytical methods.
Beets, C; Dubery, I, 2011
)
2.15
"Camalexin is a phytoalexin that accumulates in various cruciferous plants upon exposure to environmental stress and plant pathogens. "( The phytoalexin camalexin mediates cytotoxicity towards aggressive prostate cancer cells via reactive oxygen species.
Chetram, M; Hinton, C; Mezencev, R; Neal, CL; Odero-Marah, VA; Smith, BA; Vo, B, 2013
)
2.18
"Camalexin induction is a complex process, for which triggering by reactive oxygen species (ROS), salicylic acid signalling, and the glutathione status are important."( Camalexin.
Glawischnig, E, 2007
)
2.5
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
indole phytoalexin
1,3-thiazoles
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Camalexin Biosynthesis821
camalexin biosynthesis318
camalexin biosynthesis517

Bioassays (17)

Assay IDTitleYearJournalArticle
AID300484Inhibition of Sclerotina sclerotiorums brassinin glucosyl transferase assessed as specific activity at 0.30 mM2007Bioorganic & medicinal chemistry, Sep-01, Volume: 15, Issue:17
Design, synthesis, and evaluation of potential inhibitors of brassinin glucosyltransferase, a phytoalexin detoxifying enzyme from Sclerotinia sclerotiorum.
AID300478Antifungal activity against Sclerotina sclerotiorum assessed as growth inhibition at 0.05 mM after 48 hrs2007Bioorganic & medicinal chemistry, Sep-01, Volume: 15, Issue:17
Design, synthesis, and evaluation of potential inhibitors of brassinin glucosyltransferase, a phytoalexin detoxifying enzyme from Sclerotinia sclerotiorum.
AID1091682Antifungal activity against Leptosphaeria maculans assessed as inhibition of mycelial growth at 0.10 mM relative to control2009Journal of agricultural and food chemistry, Mar-25, Volume: 57, Issue:6
Synthetic inhibitors of the fungal detoxifying enzyme brassinin oxidase based on the phytoalexin camalexin scaffold.
AID1091688Inhibition of Leptosphaeria maculans brassinin oxidase assessed as relative specific activity at 0.10 mM relative to control2009Journal of agricultural and food chemistry, Mar-25, Volume: 57, Issue:6
Synthetic inhibitors of the fungal detoxifying enzyme brassinin oxidase based on the phytoalexin camalexin scaffold.
AID300486Inhibition of Sclerotina sclerotiorums brassinin glucosyl transferase assessed as percent relative activity in relative to brassinin at 0.30 mM2007Bioorganic & medicinal chemistry, Sep-01, Volume: 15, Issue:17
Design, synthesis, and evaluation of potential inhibitors of brassinin glucosyltransferase, a phytoalexin detoxifying enzyme from Sclerotinia sclerotiorum.
AID1091678Inhibition of Leptosphaeria maculans brassinin oxidase activity at 0.30 mM relative to control2009Journal of agricultural and food chemistry, Mar-25, Volume: 57, Issue:6
Synthetic inhibitors of the fungal detoxifying enzyme brassinin oxidase based on the phytoalexin camalexin scaffold.
AID1091683Inhibition of Leptosphaeria maculans brassinin oxidase assessed as relative protein at 0.50 mM relative to control2009Journal of agricultural and food chemistry, Mar-25, Volume: 57, Issue:6
Synthetic inhibitors of the fungal detoxifying enzyme brassinin oxidase based on the phytoalexin camalexin scaffold.
AID1091681Antifungal activity against Leptosphaeria maculans assessed as inhibition of mycelial growth at 0.20 mM relative to control2009Journal of agricultural and food chemistry, Mar-25, Volume: 57, Issue:6
Synthetic inhibitors of the fungal detoxifying enzyme brassinin oxidase based on the phytoalexin camalexin scaffold.
AID1091686Inhibition of Leptosphaeria maculans brassinin oxidase assessed as relative specific activity at 0.50 mM relative to control2009Journal of agricultural and food chemistry, Mar-25, Volume: 57, Issue:6
Synthetic inhibitors of the fungal detoxifying enzyme brassinin oxidase based on the phytoalexin camalexin scaffold.
AID300487Inhibition of Sclerotina sclerotiorums brassinin glucosyl transferase assessed as percent relative activity in relative to brassinin at 0.60 mM2007Bioorganic & medicinal chemistry, Sep-01, Volume: 15, Issue:17
Design, synthesis, and evaluation of potential inhibitors of brassinin glucosyltransferase, a phytoalexin detoxifying enzyme from Sclerotinia sclerotiorum.
AID1091687Inhibition of Leptosphaeria maculans brassinin oxidase assessed as relative specific activity at 0.20 mM relative to control2009Journal of agricultural and food chemistry, Mar-25, Volume: 57, Issue:6
Synthetic inhibitors of the fungal detoxifying enzyme brassinin oxidase based on the phytoalexin camalexin scaffold.
AID1091679Antifungal activity against Leptosphaeria maculans assessed as inhibition of mycelial growth at 0.50 mM relative to control2009Journal of agricultural and food chemistry, Mar-25, Volume: 57, Issue:6
Synthetic inhibitors of the fungal detoxifying enzyme brassinin oxidase based on the phytoalexin camalexin scaffold.
AID300477Antifungal activity against Sclerotina sclerotiorum assessed as growth inhibition at 0.10 mM after 48 hrs2007Bioorganic & medicinal chemistry, Sep-01, Volume: 15, Issue:17
Design, synthesis, and evaluation of potential inhibitors of brassinin glucosyltransferase, a phytoalexin detoxifying enzyme from Sclerotinia sclerotiorum.
AID1091689Inhibition of Leptosphaeria maculans brassinin oxidase activity at 0.10 mM relative to control2009Journal of agricultural and food chemistry, Mar-25, Volume: 57, Issue:6
Synthetic inhibitors of the fungal detoxifying enzyme brassinin oxidase based on the phytoalexin camalexin scaffold.
AID1091684Inhibition of Leptosphaeria maculans brassinin oxidase assessed as relative protein at 0.20 mM relative to control2009Journal of agricultural and food chemistry, Mar-25, Volume: 57, Issue:6
Synthetic inhibitors of the fungal detoxifying enzyme brassinin oxidase based on the phytoalexin camalexin scaffold.
AID300485Inhibition of Sclerotina sclerotiorums brassinin glucosyl transferase assessed as specific activity at 0.60 mM2007Bioorganic & medicinal chemistry, Sep-01, Volume: 15, Issue:17
Design, synthesis, and evaluation of potential inhibitors of brassinin glucosyltransferase, a phytoalexin detoxifying enzyme from Sclerotinia sclerotiorum.
AID1091685Inhibition of Leptosphaeria maculans brassinin oxidase assessed as relative protein at 0.10 mM relative to control2009Journal of agricultural and food chemistry, Mar-25, Volume: 57, Issue:6
Synthetic inhibitors of the fungal detoxifying enzyme brassinin oxidase based on the phytoalexin camalexin scaffold.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (188)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's12 (6.38)18.2507
2000's59 (31.38)29.6817
2010's97 (51.60)24.3611
2020's20 (10.64)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.71

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.71 (24.57)
Research Supply Index5.25 (2.92)
Research Growth Index5.03 (4.65)
Search Engine Demand Index43.31 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.71)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews8 (4.23%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other181 (95.77%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]